1.7(top 50%)
impact factor
889(top 20%)
papers
20.9K(top 10%)
citations
64(top 10%)
h-index
1.7(top 50%)
impact factor
985
all documents
22.2K
doc citations
100(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trialsDiabetes and Vascular Disease Research2015333
2Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequencesDiabetes and Vascular Disease Research2015298
3Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndromeDiabetes and Vascular Disease Research2005273
4Metformin therapy and clinical usesDiabetes and Vascular Disease Research2008252
5Homocysteine and cardiovascular disease: a review of the evidenceDiabetes and Vascular Disease Research2007235
6Metabolic syndrome, or What you will: definitions and epidemiologyDiabetes and Vascular Disease Research2007228
7The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patientsDiabetes and Vascular Disease Research2008227
8The endothelium and vascular inflammation in diabetesDiabetes and Vascular Disease Research2007223
9Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)Diabetes and Vascular Disease Research2015197
10Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetesDiabetes and Vascular Disease Research2006195
11Review article: Coagulation and fibrinolysis in diabetesDiabetes and Vascular Disease Research2010186
12Review article: Platelet abnormalities in diabetes mellitusDiabetes and Vascular Disease Research2010184
13Cellular and molecular mechanisms of endothelial dysfunction in diabetesDiabetes and Vascular Disease Research2013177
14ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – SummaryDiabetes and Vascular Disease Research2014173
15Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shiftDiabetes and Vascular Disease Research2019169
16New perspectives on the management of diabetic peripheral neuropathic painDiabetes and Vascular Disease Research2006164
17Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetesDiabetes and Vascular Disease Research2019155
18A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse modelDiabetes and Vascular Disease Research2011152
19Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) studyDiabetes and Vascular Disease Research2006150
20The impact of smoking on the development of diabetes and its complicationsDiabetes and Vascular Disease Research2017149
21The insulin resistance syndrome: physiological considerationsDiabetes and Vascular Disease Research2007140
22Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trialDiabetes and Vascular Disease Research2013132
23Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiologyDiabetes and Vascular Disease Research2013132
24Impaired glucose tolerance and impaired fasting glucose — a review of diagnosis, clinical implications and managementDiabetes and Vascular Disease Research2005128
25Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitusDiabetes and Vascular Disease Research2016122
26The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE−/− mouse modelDiabetes and Vascular Disease Research2013121
27Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritisDiabetes and Vascular Disease Research2007120
28All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individualsDiabetes and Vascular Disease Research2005116
29Thrifty genes for obesity and the metabolic syndrome — time to call off the search?Diabetes and Vascular Disease Research2006115
30Alpha-glucosidase inhibitors 2012 – cardiovascular considerations and trial evaluationDiabetes and Vascular Disease Research2012115
31Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failureDiabetes and Vascular Disease Research2004111
32The nuclear receptors Rev-erbs and RORs integrate circadian rhythms and metabolismDiabetes and Vascular Disease Research2008111
33Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitusDiabetes and Vascular Disease Research2007110
34Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitusDiabetes and Vascular Disease Research2010110
35Platelet hyperactivity in type 2 diabetes: role of antiplatelet agentsDiabetes and Vascular Disease Research2008109
36Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabeticsDiabetes and Vascular Disease Research2011109
37Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney diseaseDiabetes and Vascular Disease Research2012106
38Gaps and barriers in the control of blood glucose in people with type 2 diabetesDiabetes and Vascular Disease Research2017102
39Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studiesDiabetes and Vascular Disease Research2011101
40Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitorDiabetes and Vascular Disease Research201599
41Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseasesDiabetes and Vascular Disease Research201897
42Evaluation of sexual function in women with type 2 diabetes mellitusDiabetes and Vascular Disease Research200994
43The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysisDiabetes and Vascular Disease Research201888
44Cardiac autonomic diabetic neuropathyDiabetes and Vascular Disease Research200886
45Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration indb/dbmice by inhibiting the NF-κB pathwayDiabetes and Vascular Disease Research201485
46Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosisDiabetes and Vascular Disease Research201783
47Mammalian hibernation: a naturally reversible model for insulin resistance in man?Diabetes and Vascular Disease Research200882
48Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesisDiabetes and Vascular Disease Research201882
49Complement C3 is a novel plasma clot component with anti-fibrinolytic propertiesDiabetes and Vascular Disease Research201279
50GLP-1 receptor agonists: A clinical perspective on cardiovascular effectsDiabetes and Vascular Disease Research201278